- Every retail investor who ever bought Nasdaq-listed Enlivex shares has lost money as the stock hit an all-time low of $0.42.
- The biotech-turned-digital asset treasury (DAT) bet its balance sheet on the RAIN crypto token, which on-chain investigator ZachXBT linked to Moshe Hogeg, an Israeli entrepreneur facing a $290 million law enforcement investigation.
- Enlivex holds 78.8 billion RAIN tokens worth $1.2 billion on paper, yet its market capitalization is just $118 million — a gap indicating serious problems.
- The stock has fallen 94% over five years, and even privileged investors who bought at $1 in a November 2025 private placement have lost half their money.
As of 8:19am today in New York, every retail investor who ever bought shares of arthritis biotech-turned-digital asset treasury Enlivex on the Nasdaq has seen their investment vanish. The stock plunged to an all-time low of $0.42, capping a stunning collapse tied to a controversial crypto bet.
The company reinvented itself in November 2025 as the “world’s first prediction markets digital asset treasury strategy,” raising over $200 million at $1 per share. It appointed a former Italian prime minister to its board and spent the funds accumulating RAIN, a so-called governance token on Arbitrum that Enlivex called “the Uniswap of prediction markets.”
On-chain investigator ZachXBT flagged RAIN in May, warning that “you only provide exit liquidity for insiders” and concluding the “team is tied to a sketchy DAT Enlivex & launchpad Gems.vip.” He later traced RAIN’s funding to blockchain addresses that once moved money for two failed projects, TOMI and Data Ownership Protocol — TOMI was co-founded by Moshe Hogeg, who faces a $290 million fraud investigation. Hogeg has denied the allegations.
Consequently, the mark-to-market value of Enlivex’s RAIN holdings sits at $1.2 billion, but the token is thinly traded and much of it is pledged as collateral. The company’s own market capitalization is a mere $118 million — a clear warning sign.
Meanwhile, the stock has fallen 94% over five years, including a 30% year-to-date decline. Even the privileged investors who bought in the November placement at $1 have seen their investment cut in half.
✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.
Previous Articles:
- Kraken parent wins $22M arbitration award against ex-auditor Mazars
- New Android Malware RedWing Sold on Telegram for Bank Fraud
- SpaceX IPO Stock Recovers, Institutional Buyers Incoming
- Kenya Regulator Seeks Blockchain Analytics to Police Crypto
- Gemini launches commission-free stock trading for US customers
